Trial Profile
Clinical Trials Insight: 700008801
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Nov 2005
Price :
$35
*
At a glance
- Drugs Sufentanil (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 24 Nov 2005 New trial record.